These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1162947)

  • 61. [Clinical and immunological study of a group of children vaccinated against measles and exposed afterwards to natural measles].
    Rodriguez Rouanet E
    Rev Col Med Guatem; 1965 Dec; 16(4):210-3. PubMed ID: 5885685
    [No Abstract]   [Full Text] [Related]  

  • 62. Humoral immunogenicity to measles, rubella, and varicella-zoster vaccines in biliary atresia children.
    Wu JF; Ni YH; Chen HL; Hsu HY; Lai HS; Chang MH
    Vaccine; 2009 May; 27(21):2812-5. PubMed ID: 19366583
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reduced secretory antibody response to live attenuated measles and poliovirus vaccines in malnourished children.
    Chandra RK
    Br Med J; 1975 Jun; 2(5971):583-5. PubMed ID: 1131622
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effect of acute respiratory viral infection on the formation of postvaccinal measles immunity].
    Tikhonova NT; Prokudina IuA; Khrometskaia TM; Mamaeva TA; Ignat'eva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Dec; (12):70-5. PubMed ID: 7223193
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Immunological efficacy of smallpox vaccination in children with relative contraindications to vaccination].
    Denisov GM; Kossova ET; Rybalko DI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jan; (1):68-72. PubMed ID: 1124611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Experience with the production, control and use of live measles vaccine L-16 SSW].
    Shtarke G; Khlinak R
    Vopr Virusol; 1968; 13(6):724-9. PubMed ID: 5753361
    [No Abstract]   [Full Text] [Related]  

  • 67. [Epidemiological and immunological study of the foci of measles infection].
    Zargar'iants AI; Zemilova LP; Bolotovskií VM; Titova NS; Vurzel' GG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Sep; (9):16-20. PubMed ID: 596019
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The physico-chemical nature of anti-measles antibodies in children who have had typical measles].
    Tikhonova NT; Khrometskaia TM; Kholchev NV; Strel'tsova MP; Nesterova TP
    Vopr Virusol; 1973; 18(1):27-32. PubMed ID: 4791702
    [No Abstract]   [Full Text] [Related]  

  • 69. Measles immunity: reimmunization of children who previously received live measles vaccine and gamma globulin.
    Arbeter AM; Arthur JH; Blakeman GJ; McIntosh K
    J Pediatr; 1972 Oct; 81(4):737-41. PubMed ID: 4116365
    [No Abstract]   [Full Text] [Related]  

  • 70. A clinical and serologic study of 103 children with measles vaccine failure.
    Cherry JD; Feigin RD; Shackelford PG; Hinthorn DR; Schmidt RR
    J Pediatr; 1973 May; 82(5):802-8. PubMed ID: 4698954
    [No Abstract]   [Full Text] [Related]  

  • 71. A paediatric vaccination vector based on live attenuated measles vaccine.
    Lorin C; Combredet C; Labrousse V; Mollet L; Desprès P; Tangy F
    Therapie; 2005; 60(3):227-33. PubMed ID: 16128264
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy.
    Paunio M; Hedman K; Davidkin I; Peltola H
    Expert Opin Pharmacother; 2003 Aug; 4(8):1215-25. PubMed ID: 12877632
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Duration and degree of immunity in children vaccinated against measles].
    Klimovitskaia VE; Plotkina II; Iasina GE; Shavrova AI; Iasin AE
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Oct; (10):56-9. PubMed ID: 4454829
    [No Abstract]   [Full Text] [Related]  

  • 74. [Dynamic of measles antibody levels in subjects vaccinated with vaccines from strains L-16 and EShCh].
    Bolotovskiĭ VM; Kibrik LI; Zetilova LP; Auzinia AV; Glinskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Oct; (10):40-44. PubMed ID: 4454825
    [No Abstract]   [Full Text] [Related]  

  • 75. CLINICAL AND SEROLOGICAL OBSERVATIONS ON THE CHILDREN GIVEN ATTENUATED MEASLES VACCINE.
    ARAI M; NAKAMURA M; AKAMATSU T; KIMURA M; KITAYAMA T; KOIDE G
    Acta Paediatr Jpn; 1963 Dec; 14():9-16. PubMed ID: 14200614
    [No Abstract]   [Full Text] [Related]  

  • 76. [Results of a study of the pathogenesis of postvaccinal encephalitis].
    Dzagurov SG; Gurvich EB; Ozeretskovskiĭ NA
    Vopr Virusol; 1981; (4):398-404. PubMed ID: 6117985
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Live, further attenuated rubella vaccine. Serologic responses among term and low birth weight infants.
    Wilkins J; Wehrle PF; Portnoy B
    Am J Dis Child; 1972 Mar; 123(3):190-2. PubMed ID: 5026195
    [No Abstract]   [Full Text] [Related]  

  • 78. GLOBULIN-MODIFIED VACCINATION WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE RENAL CELLS.
    MINAMITANI M; NAKAMURA K; SHINOZAKI T; TAKAHASHI T; FUJII R; SABURI Y; MATUMOTO M
    Jpn J Exp Med; 1964 Apr; 34():85-8. PubMed ID: 14171677
    [No Abstract]   [Full Text] [Related]  

  • 79. [Clinical and serological studies on a further attenuated live measles virus AIK vaccine].
    Nino K
    Kansenshogaku Zasshi; 1973 Apr; 47(4):116-24. PubMed ID: 4199824
    [No Abstract]   [Full Text] [Related]  

  • 80. MEASLES VACCINE: RESULTS OF STUDIES WITH BOTH KILLED AND LIVE VIRUS VACCINE.
    RILEY HD
    Memphis Mid South Med J; 1964 Jul; 39():241-51. PubMed ID: 14178142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.